COVID-19的发生和症状取决于疫苗接种状况:对27,209例患者的回顾性单中心分析

Zuzanna Głowacka, Paulina Ryszka, Lidia Wydeheft, Klaudyna Grzelakowska, Michał Kasprzak, Jacek Kubica
{"title":"COVID-19的发生和症状取决于疫苗接种状况:对27,209例患者的回顾性单中心分析","authors":"Zuzanna Głowacka, Paulina Ryszka, Lidia Wydeheft, Klaudyna Grzelakowska, Michał Kasprzak, Jacek Kubica","doi":"10.5603/mrj.96746","DOIUrl":null,"url":null,"abstract":"Introduction: Widespread immunization is critical to bringing the COVID-19 pandemic to an end. The objective of this cross-sectional data analysis was to investigate the impact of vaccination on the frequency of COVID-19 occurrence and the presence of its symptoms and clinical presentations. Material and methods: This was a retrospective, cross-sectional study, analysing medical records of patients hospitalized at the Dr Antoni Jurasz University Hospital No. 1 in Bydgoszcz in the years 2019–2021. The analysis considered age, sex, vaccination status, the result of the reverse transcription polymerase chain reaction (RT-PCR) test for the detection of SARS-CoV-2 RNA, and disease symptoms and clinical presentations in accordance with ICD-10 codes. Results: The study group consisted of 27,209 patients. There were 1,393 persons (5.12%) who tested positive for COVID-19. The vaccinated patients accounted for 17.3% (n = 4,704). Those vaccinated were significantly less likely to test positive for COVID-19 (3.93% vs. 5.38%; p < 0.0001). Among unvaccinated patients with a positive test result for COVID-19, symptoms and/or clinical presentations occurred in 359 study participants (29.72%), while in vaccinated COVID-19-positive patients only in 49 persons (26.49%). The symptoms that occurred in both vaccinated and unvaccinated patients were mainly respiratory and circulatory. The most common clinical presentation, both in the group of vaccinated and unvaccinated patients, was viral pneumonia, not elsewhere classified (J12), which occurred in 17.30% and 9.19% of patients, respectively (p = 0.005). Other symptoms and clinical presentations showing a statistically significant difference in the frequency of occurrence between the groups were pneumonia in diseases classified elsewhere (J17; p = 0.019) and abnormalities of breathing (R06; p = 0.001). Conclusions: Vaccination against COVID-19 protects against symptomatic disease.","PeriodicalId":18485,"journal":{"name":"Medical Research Journal","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19 occurrence and symptoms depending on vaccination status: a retrospective single-centre analysis of 27,209 patients\",\"authors\":\"Zuzanna Głowacka, Paulina Ryszka, Lidia Wydeheft, Klaudyna Grzelakowska, Michał Kasprzak, Jacek Kubica\",\"doi\":\"10.5603/mrj.96746\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Widespread immunization is critical to bringing the COVID-19 pandemic to an end. The objective of this cross-sectional data analysis was to investigate the impact of vaccination on the frequency of COVID-19 occurrence and the presence of its symptoms and clinical presentations. Material and methods: This was a retrospective, cross-sectional study, analysing medical records of patients hospitalized at the Dr Antoni Jurasz University Hospital No. 1 in Bydgoszcz in the years 2019–2021. The analysis considered age, sex, vaccination status, the result of the reverse transcription polymerase chain reaction (RT-PCR) test for the detection of SARS-CoV-2 RNA, and disease symptoms and clinical presentations in accordance with ICD-10 codes. Results: The study group consisted of 27,209 patients. There were 1,393 persons (5.12%) who tested positive for COVID-19. The vaccinated patients accounted for 17.3% (n = 4,704). Those vaccinated were significantly less likely to test positive for COVID-19 (3.93% vs. 5.38%; p < 0.0001). Among unvaccinated patients with a positive test result for COVID-19, symptoms and/or clinical presentations occurred in 359 study participants (29.72%), while in vaccinated COVID-19-positive patients only in 49 persons (26.49%). The symptoms that occurred in both vaccinated and unvaccinated patients were mainly respiratory and circulatory. The most common clinical presentation, both in the group of vaccinated and unvaccinated patients, was viral pneumonia, not elsewhere classified (J12), which occurred in 17.30% and 9.19% of patients, respectively (p = 0.005). Other symptoms and clinical presentations showing a statistically significant difference in the frequency of occurrence between the groups were pneumonia in diseases classified elsewhere (J17; p = 0.019) and abnormalities of breathing (R06; p = 0.001). Conclusions: Vaccination against COVID-19 protects against symptomatic disease.\",\"PeriodicalId\":18485,\"journal\":{\"name\":\"Medical Research Journal\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Research Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/mrj.96746\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Research Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/mrj.96746","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导言:广泛接种疫苗对于终结COVID-19大流行至关重要。本横断面数据分析的目的是调查疫苗接种对COVID-19发生频率及其症状和临床表现的影响。材料和方法:这是一项回顾性横断面研究,分析了2019-2021年在比得哥什Antoni Jurasz博士大学第一医院住院的患者的医疗记录。分析考虑了年龄、性别、疫苗接种情况、检测SARS-CoV-2 RNA的逆转录聚合酶链反应(RT-PCR)结果,以及符合ICD-10代码的疾病症状和临床表现。结果:研究组包括27,209例患者。新冠病毒检测阳性1393人(5.12%)。接种疫苗的患者占17.3% (n = 4704)。接种疫苗的人COVID-19检测呈阳性的可能性显著降低(3.93%对5.38%;p & lt;0.0001)。在COVID-19检测结果呈阳性的未接种疫苗的患者中,359名研究参与者(29.72%)出现了症状和/或临床表现,而在接种了COVID-19疫苗的阳性患者中,只有49人(26.49%)出现了症状和/或临床表现。接种疫苗和未接种疫苗的患者均以呼吸道和循环系统症状为主。在接种疫苗和未接种疫苗的患者组中,最常见的临床表现是病毒性肺炎,未在其他地方分类(J12),分别发生在17.30%和9.19%的患者中(p = 0.005)。组间出现频率有统计学显著差异的其他症状和临床表现有:其他分类疾病中的肺炎(J17;p = 0.019)和呼吸异常(R06;P = 0.001)。结论:COVID-19疫苗接种可预防症状性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 occurrence and symptoms depending on vaccination status: a retrospective single-centre analysis of 27,209 patients
Introduction: Widespread immunization is critical to bringing the COVID-19 pandemic to an end. The objective of this cross-sectional data analysis was to investigate the impact of vaccination on the frequency of COVID-19 occurrence and the presence of its symptoms and clinical presentations. Material and methods: This was a retrospective, cross-sectional study, analysing medical records of patients hospitalized at the Dr Antoni Jurasz University Hospital No. 1 in Bydgoszcz in the years 2019–2021. The analysis considered age, sex, vaccination status, the result of the reverse transcription polymerase chain reaction (RT-PCR) test for the detection of SARS-CoV-2 RNA, and disease symptoms and clinical presentations in accordance with ICD-10 codes. Results: The study group consisted of 27,209 patients. There were 1,393 persons (5.12%) who tested positive for COVID-19. The vaccinated patients accounted for 17.3% (n = 4,704). Those vaccinated were significantly less likely to test positive for COVID-19 (3.93% vs. 5.38%; p < 0.0001). Among unvaccinated patients with a positive test result for COVID-19, symptoms and/or clinical presentations occurred in 359 study participants (29.72%), while in vaccinated COVID-19-positive patients only in 49 persons (26.49%). The symptoms that occurred in both vaccinated and unvaccinated patients were mainly respiratory and circulatory. The most common clinical presentation, both in the group of vaccinated and unvaccinated patients, was viral pneumonia, not elsewhere classified (J12), which occurred in 17.30% and 9.19% of patients, respectively (p = 0.005). Other symptoms and clinical presentations showing a statistically significant difference in the frequency of occurrence between the groups were pneumonia in diseases classified elsewhere (J17; p = 0.019) and abnormalities of breathing (R06; p = 0.001). Conclusions: Vaccination against COVID-19 protects against symptomatic disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Optimal timing of postoperative radiotherapy initiation in maxillary sinus cancer patients Aftereffects of delayed intracavitary brachytherapy in cancer cervix patients during COVID-19 lockdown — a tertiary care centre review Influence on polymorphism of visfatin (rs 4730153) and nesfatin (rs 1330) genes on the development of the metabolic syndrome Optimal timing of postoperative radiotherapy initiation in maxillary sinus cancer patients Influence on polymorphism of visfatin (rs 4730153) and nesfatin (rs 1330) genes on the development of the metabolic syndrome
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1